Clinical trial
Topical Morphine for Analgesia in Patients With Skin Grafts
NCT00362219 · Rambam Health Care Campus, Other · Withdrawn
Key facts
| NCT number | NCT00362219 |
|---|---|
| Title | Topical Morphine for Analgesia in Patients With Skin Grafts |
| Official title | Topical Morphine for Analgesia in Patients With Skin Grafts |
| Lead sponsor | Rambam Health Care Campus, Other |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Skin Transplantation, Pain |
| Intervention type | Drug, Other |
| Interventions | Placebo, Morphine - .25 mg, Morphine |
| Enrollment | 0 |
| Start date | Jan 1, 2022 |
| Primary completion | Dec 1, 2023 |
| Completion | Dec 1, 2024 |
| First posted | Aug 9, 2006 |
| Last update posted | May 3, 2022 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: